发明名称 |
CONTROLLED DRUG RELEASE LIPOSOME COMPOSITION |
摘要 |
The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein. |
申请公布号 |
CA2906149(A1) |
申请公布日期 |
2014.09.18 |
申请号 |
CA20142906149 |
申请日期 |
2014.03.15 |
申请人 |
TAIWAN LIPOSOME COMPANY, LTD.;TLC BIOPHARMACEUTICALS, INC. |
发明人 |
KAN, PEI;TSENG, YUN-LONG;OU, HAN CHUN |
分类号 |
A61K9/127 |
主分类号 |
A61K9/127 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|